Literature DB >> 23553048

Analysis of thiopurine S-methyltransferase phenotype-genotype in a Tunisian population with Crohn's disease.

Lynda Ben Salah1, Mouna Belkhiria el Haj Amor, Chahra Chbili, Saida Khlifi, Neila Fathallah, Iheb Bougmiza, Elhem Ben Jazia, Nicole Houdret, Chaker Ben Salem, Saad Saguem.   

Abstract

This study was conducted to investigate the thiopurine S-methyltransferase TPMT activity distribution and gene mutations in Tunisian population with positive diagnostic for Crohn's disease. TPMT activity was measured in Tunisian population (n = 88) by a high performance liquid chromatography assay. Polymerase chain reaction-based methods were used to determine the frequency of TPMT mutant alleles TPMT*2, TPMT*3A, TPMT*3B and TPMT*3C. TPMT activity was normally distributed, ranging from 4.58 to 35.27 nmol/(h ml) RBC with a mean of 18.67 ± 7.10 nmol/(h ml) RBC. Seven TPMT*3A heterozygotes and one TPMT*3C homozygote were found in 88 patients, with allele frequencies of 0.039 and 1.13, respectively. TPMT*3A and the TPMT*3C, which cause the largest decrease in enzyme activity, were both variant alleles detected in the Tunisian population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23553048     DOI: 10.1007/s13318-013-0127-z

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  15 in total

1.  The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.

Authors:  E S Collie-Duguid; S C Pritchard; R H Powrie; J Sludden; D A Collier; T Li; H L McLeod
Journal:  Pharmacogenetics       Date:  1999-02

2.  Thiopurine methyltransferase alleles in British and Ghanaian populations.

Authors:  M M Ameyaw; E S Collie-Duguid; R H Powrie; D Ofori-Adjei; H L McLeod
Journal:  Hum Mol Genet       Date:  1999-02       Impact factor: 6.150

3.  Thiopurine methyltransferase genotype and phenotype status in Japanese patients with systemic lupus erythematosus.

Authors:  Yuko Okada; Katsunori Nakamura; Tomoko Kodama; Kazue Ueki; Yoshito Tsukada; Akira Maezawa; Norifumi Tsukamoto; Yoshihisa Nojima; Takashi Ishizaki; Ryuya Horiuchi; Koujirou Yamamoto
Journal:  Biol Pharm Bull       Date:  2005-11       Impact factor: 2.233

4.  Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia.

Authors:  H L McLeod; S Coulthard; A E Thomas; S C Pritchard; D J King; S M Richards; O B Eden; A G Hall; B E Gibson
Journal:  Br J Haematol       Date:  1999-06       Impact factor: 6.998

5.  Thiopurine methyl transferase activity: new extraction conditions for high-performance liquid chromatographic assay.

Authors:  C Ganiere-Monteil; A Pineau; M F Kergueris; C Azoulay; M Bourin
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1999-04-30

6.  Molecular analysis of thiopurine S-methyltransferase alleles in South-east Asian populations.

Authors:  Jan-Gowth Chang; Long-Shyong Lee; Chih-Mei Chen; Mu-Chin Shih; Mei-Chen Wu; Fuu-Jen Tsai; Der-Cheng Liang
Journal:  Pharmacogenetics       Date:  2002-04

7.  Thiopurine methyltransferase polymorphisms and mercaptopurine tolerance in Turkish children with acute lymphoblastic leukemia.

Authors:  Meryem Albayrak; Uljan Konyssova; Zuhre Kaya; Turkiz Gursel; Sezen Guntekin; E Ferda Percin; Ulker Kocak
Journal:  Cancer Chemother Pharmacol       Date:  2011-03-13       Impact factor: 3.333

8.  Allelotype frequency of the thiopurine methyltransferase (TPMT) gene in Japanese.

Authors:  K Kumagai; K Hiyama; S Ishioka; H Sato; Y Yamanishi; H L McLeod; F Konishi; H Maeda; M Yamakido
Journal:  Pharmacogenetics       Date:  2001-04

9.  Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.

Authors:  R M Weinshilboum; S L Sladek
Journal:  Am J Hum Genet       Date:  1980-09       Impact factor: 11.025

10.  The low frequency of defective TPMT alleles in Turkish population: a study on pediatric patients with acute lymphoblastic leukemia.

Authors:  Tugba Boyunegmez Tumer; Gulen Ulusoy; Orhan Adali; Gurses Sahin; Sevgi Gozdasoglu; Emel Arinç
Journal:  Am J Hematol       Date:  2007-10       Impact factor: 10.047

View more
  3 in total

1.  Preclinical evaluation of NUDT15-guided thiopurine therapy and its effects on toxicity and antileukemic efficacy.

Authors:  Rina Nishii; Takaya Moriyama; Laura J Janke; Wenjian Yang; Chase C Suiter; Ting-Nien Lin; Lie Li; Kentaro Kihira; Hidemi Toyoda; Ute Hofmann; Matthias Schwab; Masatoshi Takagi; Tomohiro Morio; Atsushi Manabe; Shirley Kham; Nan Jiang; Karen R Rabin; Motohiro Kato; Katsuyoshi Koh; Allen Eng-Juh Yeoh; Hiroki Hori; Jun J Yang
Journal:  Blood       Date:  2018-03-23       Impact factor: 22.113

2.  Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: a systematic review.

Authors:  Lilla M Roy; Richard M Zur; Elizabeth Uleryk; Chris Carew; Shinya Ito; Wendy J Ungar
Journal:  Pharmacogenomics       Date:  2016-03-29       Impact factor: 2.533

Review 3.  Thiopurine S-methyltransferase testing for averting drug toxicity: a meta-analysis of diagnostic test accuracy.

Authors:  R M Zur; L M Roy; S Ito; J Beyene; C Carew; W J Ungar
Journal:  Pharmacogenomics J       Date:  2016-05-24       Impact factor: 3.550

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.